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CASE REPORT
Idiopathic adulthood ductopenia (IAD) is a chronic cholestatic liver disease of unknown etiology characterized by
adult onset, an absence of autoantibodies, inflammatory bowel disease, and a loss of interlobular bile ducts. In the
present report, a case fulfilling the IAD criteria is described. A 19-year-old man was admitted to the hospital for
persistent elevation of transaminases and alkaline phosphatase without clinical symptoms. Viral hepatitis markers
and autoantibodies were absent. The patient had a normal extrahepatic biliary tree and had no evidence of
inflammatory bowel disease. A liver biopsy specimen showed absence of interlobular bile ducts from 58% of the
portal tracts. He was diagnosed with IAD and was treated with ursodeoxycholic acid. (Korean J Intern Med
2009;24:270-273)
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INTRODUCTION
Idiopathic adulthood ductopenia (IAD) was first pro-
posed as a condition characterized by chronic cholestasis
by Ludwig et al. in 1988 [1]. Currently, the diagnosis of
IAD is considered with adult or adolescent onset, bio-
chemical evidence of cholestatic liver disease, evidence of
ductopenia by liver biopsy with normal cholangiography,
and an unknown etiology. A diagnosis of IAD requires
exclusion of other conditions with chronic cholestasis that
are associated with ductopenia [1-3]. To date, less than
100 cases have been reported in the medical literature,
with only 1 prior case in Korea [4]. We report a case of
idiopathic adulthood ductopenia with a brief review of the
medical literature.
CASE REPORT
A 19-year-old man who had abnormal liver function
tests (LFTs) was referred to the outpatient clinic. Four
years and 1 month earlier, abnormal LFTs were detected
repeatedly, but the patient remained asymptomatic. He
had no history of neonatal or infantile liver disease,
previous drug treatments, jaundice, itching, or abdominal
pain. There was no history of smoking, alcohol drinking
and any medication treatments. His mother was diagnosed
with chronic type B hepatitis. Physical examination
showed no abnormal findings. Laboratory tests revealed
the following findings: hemoglobin 14.5 g/dL, white blood
count 7090/mm
3, platelets 376,000/mm
3, alanine
aminotransferase (ALT) 147 IU/L, aspartate aminotrans-
ferase (AST) 123 IU/L, alkaline phosphatase (ALP) 1345
IU/L, γ-glutamyl transpeptidase (GGT) 576 IU/L, total
bilirubin 0.9 mg/dL and albumin 4.0 g/dL. Serum iron,
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ceruloplasmin were normal. Serological tests for anti-
smooth muscle, anti-neutrophil-cytoplasm, anti-nuclear,
anti-mitochondrial, anti-liver-kidney microsome
antibodies, hepatitis B surface antigen, and hepatitis C
virus serology were negative. 
An abdominal CT showed normal echogenicity of the
liver. No evidence of cholelithiasis or biliary dilation was
noted (Fig. 1). During a six-month follow-up period, his
LFTs showed persistent elevation of the transaminases
and alkaline phosphatase without clinical symptoms. He
was admitted to the hospital for further evaluation. An
endoscopic retrograde cholangiopancreatography
(ERCP) demonstrated completely normal extrahepatic
bile ducts and minimal irregularities of the intrahepatic
bile ducts in the left lobe (Fig. 2). A colonoscopy was normal.
Percutaneous liver biopsy showed a lack of interlobular
bile ducts. In 19 portal tracts, only eight bile ducts were
found. Mild chronic inflammatory infiltrates consisting
primarily of lymphocytes and liver parenchymal spotty
necrosis were also found (Fig. 3). The patient was diagnosed
with idiopathic adulthood ductopenia. Treatment was
started with ursodeoxycholic acid at doses of 300 mg
twice daily and changed to 200 mg twice daily with
vitamins. Eight months later, the laboratory test results
were AST, 52 IU/L; ALT, 64 IU/L; GGT, 112 IU/L; ALP,
208 IU/L; and total bilirubin 0.9 mg/dL (Fig. 4).
Figure 1. Abdominal CT scan showing a normal liver. No
evidence of cholelithiasis or biliary dilation is noted.
Figure 3. Histology findings of the liver biopsy specimen
(H&E, × 200). Branches of the hepatic artery (arrow) and portal
vein (star shape) are present in the portal tract. However,
interlobular bile ducts are absent. In this portal tract, there is a
mild chronic inflammatory infiltrate including lymphocytes and
plasma cells.
Although the lobular inflammation is mild, a focus of spotty
necrosis is noted (arrow head). Piecemeal activity is absent.
Figure 4. Liver function test (LFT) profiles. LFTs show
persistent elevation of transaminases and alkaline phosphatase
(ALP) during a six month follow-up period. After treatment with
urosodeoxycholic acid (UDCA), LFTs improved. AST, aspartate
aminotransferase; ALT, alanine aminotransferase; GGT, γ-
glutamyl transpeptidase.
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Figure 2. An endoscopic retrograde cholangiopancreatography
(ERCP) demonstrates completely normal extrahepatic bile ducts
and minimal irregularities of the intrahepatic bile ducts in the
left lobe (arrow).272 The Korean Journal of Internal Medicine Vol. 24, No. 3, September 2009
DISCUSSION
Primary biliary cirrhosis (PBC) and primary sclerosing
cholangitis (PSC) are the most common causes of chronic
progressive cholestasis in adults [5,6]. However, a small
number of patients who present with chronic cholestasis,
lack anti-mitochondrial antibodies for PBC and have
cholangiographic abnormalities consistent with PSC.
These groups of patients often are thought to have AMA-
negative PBC, small-duct PSC, or idiopathic adulthood
ductopenia [7]. Ludwig reported the causes of small duct
biliary diseases in 2,082 cases diagnosed between 1988
and 1994 at the Mayo Clinic. While PBC and PSC accounted
for more than 90% of the cases with small duct biliary
diseases, IAD was present in only 1% of cases [2]. In Korea,
only one case in 2004, a 28-year-old woman who presented
with pruritus and jaundice, has been reported [4].
The etiology of IAD is unknown. Several possible causes
have been suggested, including late onset nonsyndromic
paucity of the intrahepatic bile ducts, small-duct PSC
without large duct involvement and without evidence of
inflammatory bowel disease, nonsuppurative viral
cholangitis, hepatitis C virus, and autoimmune cholangitis
or cholangitis in autoimmune hepatitis, in the absence of
typical autoantibodies [1,2,8,9]. Typically, IAD is more
common in males (M:F, 1.8:1), and it is usually diagnosed
in young or middle-aged adults (15-77 years, median age:
34 years, 30 years for male, 36 years for female) [1,2].
However, each etiologic group appears to have a different
age distribution. Late onset nonsyndromic paucity of
intrahepatic bile ducts usually is diagnosed in the teenage
years and nonsuppurative viral cholangitis in adults more
than 40 years of age [1,2]. This case appears to belong to
the late-onset nonsyndromic paucity of intrahepatic bile
ducts, as abnormal LFTs have been identified in
teenagers.
Ductopenia by liver biopsy is the criterion necessary for
the diagnosis of IAD. Ductopenia is defined as the loss of
interlobular and septal bile ducts of more than 50%
among 20 or more portal tracts [1,2,10]. Clinical symptoms
include jaundice, pruritus and fatigue. Approximately
one-third of patients present with episodic jaundice and
pruritus, which gradually worsens. In other patients,
cholestasis progresses incessantly, although the rate of
deterioration varies [7]. Laboratory findings demonstrate
the cholestatic profiles. Direct bilirubin levels are
frequently increased. ALP and GGT are increased more
than three times the upper limit of normal. Transaminase
levels vary between normal and a 10-fold increases [1,2,7].
In this case, there was a persistent cholestatic pattern of
LFTs with a normal bilirubin.
Treatments for IAD depend on the etiology and the
severity of the clinical course [11,12]. IAD related to
autoimmune hepatitis or viral hepatitis requires specific
treatments. In advanced cases, liver transplantation is the
treatment of choice [13,14]. In cases that are not severe,
ursodeoxycholic acid (UDCA) can be used for treatment. A
beneficial effect with the treatment of UDCA has been
suggested, but its impact on the progression of the disease
is unknown [11,12]. 
The clinical outcome may be dependent on the cause of
the disease and on the degree of ductopenia. Most patients
with a late-onset nonsyndromic paucity of the intrahepatic
bile ducts and small-duct primary sclerosing cholangitis
may have progressive disease, but this may be self-limited
in patients with virus-related cholangitis and autoimmune
cholangitis [2,11,12]. Typically, IAD eventually progresses
to end-stage liver disease. However, some patients with
mild to moderate loss of intrahepatic bile ducts, less than
50% based on a liver biopsy, have a benign course [2,8,11].
Mild IAD, also termed mild idiopathic biliary ductopenia,
does not meet the current diagnostic criteria for IAD as no
cases have had ductopenia involving 50% of the portal
tracts [11]. However, they appear to have features consistent
with this diagnosis. Our patient had only abnormal LFTs
without any symptoms, but had a ductopenia of more
than 50%. Whether his course will be benign is not clear at
this time. IAD is a progressive disease and our patient may
have been diagnosed at an early stage.
In conclusion, little is known about IAD. The patho-
genesis, causes, clinical course, and best treatments
remain unclear. IAD is not a specific single entity but a
syndrome associated with variable etiologies and variable
clinical outcomes.
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